Original Article

Pyrrolidinedithiocarbamic Acid Ammonium Salt Inhibits Apoptosis and Phenotypic Transformation of Co-Culture of Myeloma Cells and Renal Tubular Epithelial Cells by Reducing the Secretion of Light Chain Protein

Abstract

Background: We investigate the effects of NFκB inhibitor pyrrolidinedithiocarbamic acid ammonium salt (PDTC) on the viability, apoptosis and cell phenotype of HK-2 cells in the co-culture system of myeloma cells in renal tubular epithelial cells.

Methods: This study was performed in Qiqihar Medical University, Qiqihar, China from Jun 2018 to Jan 2019. RPMI-8226 cells and HK-2 cells were inoculated in the co-culture chamber and cultured to establish the co-culture system. An immunoturbidimetric assay was performed to detect κ light chain and λ light chain in RPMI-8226 cells. The effect of PDTC on the secretion of κ light chain and λ light chain of RPMI-8226 cells was detected by immunoturbidimetry and the ratio was calculated.

Results: PDTC significantly increased the viability of HK-2 cells. PDTC reduced the apoptosis of renal tubular epithelial cells. After PDTC treatment, the expression of cell surface marker E-cadherin decreased, and the expression of α-SMA increased, which induced the renal interstitial fibrosis. The secretion of κ light chain and λ light chain of RPMI-8226 cells was significantly decreased after the addition of PDTC, but the ratio was not changed.

Conclusion: PDTC can inhibit the cell activity, promote apoptosis, and reduce the secretion of secretion of κ light chain and λ light chain through inhibiting the NF-κB pathway activation of myeloma cell RPMI-8226.

1. Kastritis E, Terpos E, Dimopoulos MA (2013). Current treatments for renal failure due to multiple myeloma. Expert Opin Pharmacother, 14(11): 1477-95.
2. Bilyy R, Tomin A, Mahorivska I, et al (2011). Antibody-mediated sialidase activity in blood serum of patients with multiple myeloma. J MolRecognit, 24(4): 576-84.
3. Ying WZ, Sanders PW (2001). Mapping the binding domain of immunoglobulin light chains for Tamm-Horsfall protein. Am J Pathol, 158(5): 1859-66.
4. Zhao A, Kong F, Liu CJ, et al (2017). Tumor Cell-Derived Microvesicles Induced Not Epithelial-Mesenchymal Transition but Apoptosis in Human Proximal Tubular (HK-2) Cells: Implications for Renal Impairment in Multiple Myeloma. Int J Mol Sci, 18(3): 513.
5. Wang PX, Sanders PW (2007). Immunoglobulin light chains generate hydrogen peroxide. J Am Soc Nephrol, 18(4): 1239-45.
6. Li ZW, Chen H, Campbell RA, et al (2008). NF-kappaB in the pathogenesis and treatment of multiple myeloma. Curr Opin Hematol, 15(4): 391-9.
7. Hideshima T, Chauhan D, Richardson P, et al (2002). NF-kappa B as a therapeutic target in multiple myeloma. J Biol Chem, 277(19): 16639-47.
8. Kumar SK, Lee JH, Lahuerta JJ, et al (2012). Risk of progression and survival in multiple myeloma relapsing after therapy with IMiDs and bortezomib: a multicenter international myeloma working group study. Leukemia, 26(1): 149-57.
9. Rumpold H, Salvador C, Wolf AM, et al (2007). Knockdown of PgP resensitizes leukemic cells to proteasome inhibitors. Biochem Biophys Res Commun, 361(2): 549-54.
10. Adams J (2004). The development of proteasome inhibitors as anticancer drugs. Cancer Cell, 5(5): 417-21.
11. Annunziata CM, Davis RE, Demchenko Y, et al (2007). Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell, 12(2): 115-30.
12. Parker KM, Ma MH, Manyak S, et al (2002). Identification of polymorphisms of the IkappaBalpha gene associated with an increased risk of multiple myeloma. Cancer Genet Cytogenet, 137(1): 43-8.
13. Bahlis NJ, King AM, Kolonias D, et al (2007). CD28-mediated regulation of multiple myeloma cell proliferation and survival. Blood, 109(11): 5002-10.
14. Anto RJ, Mukhopadhyay A, Shishodia S, et al (2002). Cigarette smoke condensate activates nuclear transcription factor-kappaB through phosphorylation and degradation of IkappaB(alpha): correlation with induction of cyclooxygenase-2. Carcinogenesis, 23(9): 1511-8.
15. Hassan SB, Gali-Muhtasib H, Göransson H, et al (2010). Alpha terpineol: a potential anticancer agent which acts through suppressing NF-kappaB signalling. Anticancer Res, 30(6): 1911-9.
16. Rajkumar SV, Dimopoulos MA, Palumbo A, et al (2014). International Myeloma Working Group updated criteria for the diagnosis of multiple myeloma. Lancet Oncol, 15(12): e538-48.
17. Paul S, Li L, Kalaga R, et al (1995). Natural catalytic antibodies: peptide-hydrolyzing activities of Bence Jones proteins and VL fragment. J Biol Chem, 270(25): 15257-61.
18. Matsuura K, Sinohara H (1996). Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginylglycinamide bond. Biol Chem, 377(9): 587-9.
19. Shuster AM, Gololobov GV, Kvashuk OA, et al (1992). DNA hydrolyzing autoantibodies. Science, 256(5057): 665-7.
20. Matsuura K, Sinohara H (1996). Catalytic cleavage of vasopressin by human Bence Jones proteins at the arginylglycinamide bond. Biol Chem, 377(9): 587-9.
21. Sanders PW, Herrera GA, Galla JH (1987). Human Bence Jones protein toxicity in rat proximal tubule epithelium in vivo. Kidney Int, 32(6): 851-61.
22. Siezenga MA, van der Geest RN, Mallat MJ, et al (2010). Urinary properdin excretion is associated with intrarenal complement activation and poor renal function. Nephrol Dial Transplant, 25(4): 1157-1161.
23. Liu Y (2011). Cellular and molecular mechanisms of renal fibrosis. Nat Rev Nephrol, 7(12): 684-96.
24. Grande MT, Sánchez-Laorden B, López-Blau C, et al (2016). Erratum: Snail1-induced partial epithelial-to-mesenchymal transition drives renal fibrosis in mice and can be targeted to reverse established disease. Nat Med, 22(2): 217.
25. Lovisa S, LeBleu VS, Tampe B, et al (2015). Epithelial-to-mesenchymal transition induces cell cycle arrest and parenchymal damage in renal fibrosis. Nat Med, 21(9): 998-1009.
Files
IssueVol 49 No 11 (2020) QRcode
SectionOriginal Article(s)
Published2020-10-27
DOI https://doi.org/10.18502/ijph.v49i11.4723
Keywords
Myeloma nephropathy Renal tubular epithelial cells Light chain protein

Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
1.
YU X, BAO J, CUI X, DU F, WANG Y, BI L, SUN J, LI L. Pyrrolidinedithiocarbamic Acid Ammonium Salt Inhibits Apoptosis and Phenotypic Transformation of Co-Culture of Myeloma Cells and Renal Tubular Epithelial Cells by Reducing the Secretion of Light Chain Protein. Iran J Public Health. 49(11):2078-2086.